Recordati buys rights to rare immune disorder drug from Sanofi for $825 mln - Reuters

Reuters | Oct. 4, 2024, 3:52 a.m. | Original
Recordati buys rights to rare immune disorder drug from Sanofi for $825 mln Reuters
Taiwan re-opens, mopping up after Typhoon Krathon - Reuters Asia Gold Festivities spark slight demand in India, China on holiday - Reuters